CY1866A - (1H-azol-1-ylmethyl)substituted benzotriazole derivatives - Google Patents

(1H-azol-1-ylmethyl)substituted benzotriazole derivatives

Info

Publication number
CY1866A
CY1866A CY186688A CY186688A CY1866A CY 1866 A CY1866 A CY 1866A CY 186688 A CY186688 A CY 186688A CY 186688 A CY186688 A CY 186688A CY 1866 A CY1866 A CY 1866A
Authority
CY
Cyprus
Prior art keywords
azol
ylmethyl
benzotriazole derivatives
substituted benzotriazole
substituted
Prior art date
Application number
CY186688A
Other languages
English (en)
Inventor
Alfons H M Raeymaekers
Eddy J E Freyne
Van Josephus L H Gelder
Marc G Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY1866A publication Critical patent/CY1866A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY186688A 1987-06-01 1988-05-26 (1H-azol-1-ylmethyl)substituted benzotriazole derivatives CY1866A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5602187A 1987-06-01 1987-06-01

Publications (1)

Publication Number Publication Date
CY1866A true CY1866A (en) 1988-05-26

Family

ID=22001654

Family Applications (1)

Application Number Title Priority Date Filing Date
CY186688A CY1866A (en) 1987-06-01 1988-05-26 (1H-azol-1-ylmethyl)substituted benzotriazole derivatives

Country Status (24)

Country Link
EP (1) EP0293978B1 (ko)
JP (1) JPH0662612B2 (ko)
KR (1) KR970000952B1 (ko)
CN (1) CN1022184C (ko)
AU (1) AU603446B2 (ko)
BG (2) BG50278A3 (ko)
CA (1) CA1307271C (ko)
CY (1) CY1866A (ko)
DE (1) DE3884055T2 (ko)
DK (1) DK175218B1 (ko)
ES (1) ES2059490T3 (ko)
FI (1) FI90078C (ko)
HK (1) HK114795A (ko)
HU (2) HU201056B (ko)
IE (1) IE61823B1 (ko)
IL (1) IL86551A (ko)
LT (1) LT3950B (ko)
LV (1) LV10452B (ko)
NO (1) NO169900C (ko)
NZ (1) NZ224714A (ko)
PT (1) PT87623B (ko)
RU (1) RU1838308C (ko)
UA (1) UA11192A (ko)
ZA (1) ZA883861B (ko)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
DE59010171D1 (de) * 1989-07-14 1996-04-11 Ciba Geigy Ag Substituierte Benzonitrile
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
NZ236440A (en) * 1989-12-15 1993-07-27 Merck & Co Inc Reversal of sexual phenotype in poultry using an inhibitor of steroid biotransformation and/or aromatase inhibitor, poultry produced by this process
EP0445073A1 (de) * 1990-02-27 1991-09-04 Ciba-Geigy Ag Benzofurane
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (ko) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
TW210334B (ko) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
RO114129B1 (ro) 1991-09-02 1999-01-29 Yamanouchi Pharmaceutical Co., Ltd. Derivaţi aminici terţiari substituiţi cu triazolil
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤
AU679704B2 (en) * 1992-11-10 1997-07-10 Janssen Pharmaceutica N.V. Process for preparing enantiomerically pure 6-((4-chlorophenyl)(1H-triazol-1,2,4-triazol-1-YL)methyl)- 1-methyl-1H-benzotriazole
CA2150326A1 (en) * 1994-05-27 1995-11-28 Kimihiro Murakami Azolyl methyl phenyl derivatives having aromatase inhibitory activity
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
EP0949242A4 (en) * 1996-12-24 2004-09-08 Chugai Seiyakukabushiki Kaisha AROMATIC AMINE DERIVATIVES HAVING AN INHIBITORY ACTION WITH RESPECT TO OUR
EP1295880A4 (en) * 2000-06-28 2004-05-06 Ssp Co Ltd IMIDAZOLE DERIVATIVES OR SALTS THEREOF, AND MEDICINAL PRODUCTS CONTAINING DERIVATIVES OR SALTS
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
EP1606283B1 (en) * 2003-03-03 2008-10-08 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
EP1874304B1 (en) * 2005-04-29 2009-07-15 Janssen Pharmaceutica N.V. Benzotriazole derivatives as cannabinoid receptor antagonists
US7572807B2 (en) * 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US8361996B2 (en) 2005-09-15 2013-01-29 Council Of Scientific And Industrial Research Imidazolyl substituted steroidal and indan-1-one derivatives
MY151835A (en) 2006-01-31 2014-07-14 Array Biopharma Inc Kinase inhibitors and methods of use thereof
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2630136A1 (en) * 2010-10-21 2013-08-28 Universität des Saarlandes Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (ko) * 1980-10-23 1984-07-13 Pfizer
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
DE3744589C1 (de) 1987-12-31 1988-12-29 Albrecht Josef Bohrfutter Nachspannendes Bohrfutter

Also Published As

Publication number Publication date
CN88103408A (zh) 1988-12-14
KR890000469A (ko) 1989-03-14
CN1022184C (zh) 1993-09-22
ZA883861B (en) 1990-01-31
IL86551A (en) 1992-07-15
PT87623B (pt) 1992-09-30
BG60429B2 (bg) 1995-03-31
RU1838308C (ru) 1993-08-30
DE3884055T2 (de) 1994-01-27
AU603446B2 (en) 1990-11-15
IL86551A0 (en) 1988-11-15
FI882552A (fi) 1988-12-02
JPH0662612B2 (ja) 1994-08-17
HK114795A (en) 1995-07-21
DK295288A (da) 1988-12-02
IE61823B1 (en) 1994-11-30
EP0293978A3 (en) 1990-06-13
AU1653788A (en) 1988-12-01
HU211482A9 (en) 1995-11-28
NO169900C (no) 1992-08-19
PT87623A (pt) 1988-06-01
JPS63316775A (ja) 1988-12-26
NO169900B (no) 1992-05-11
FI90078C (fi) 1993-12-27
NO882390D0 (no) 1988-05-31
FI90078B (fi) 1993-09-15
EP0293978B1 (en) 1993-09-15
IE881640L (en) 1988-12-01
CA1307271C (en) 1992-09-08
LT3950B (en) 1996-05-27
FI882552A0 (fi) 1988-05-31
ES2059490T3 (es) 1994-11-16
NZ224714A (en) 1990-03-27
EP0293978A2 (en) 1988-12-07
UA11192A (uk) 1996-12-25
LV10452A (lv) 1995-02-20
BG50278A3 (en) 1992-06-15
LV10452B (en) 1995-08-20
HUT49132A (en) 1989-08-28
HU201056B (en) 1990-09-28
LTIP1625A (en) 1995-07-25
KR970000952B1 (ko) 1997-01-21
DE3884055D1 (de) 1993-10-21
DK295288D0 (da) 1988-05-31
DK175218B1 (da) 2004-07-12
NO882390L (no) 1988-12-02

Similar Documents

Publication Publication Date Title
ZA883861B (en) (1h-azol-1-ylmethyl)substituted benzotriazole derivatives
GR3002864T3 (en) Azolylmethylcyclopropyl derivatives
GB8815258D0 (en) Thiorea derivatives
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
EP0297383A3 (en) Hydroxyethyl-azolyl derivatives
IL88134A0 (en) Substituted azacyclohexyl derivatives
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
EP0322164A3 (en) Ethanolamie derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
ZA887966B (en) Substituted azacyclohexyl derivatives
GB8726272D0 (en) 4-demethoxy anthra-cycline derivatives
GB2200910B (en) Thiopilocarpine derivatives
GB8704236D0 (en) Anthracycline-oestrone derivatives
ZA881332B (en) Certain thienothiopyran derivatives
GB8700016D0 (en) Quinolizinone derivatives
SG118794G (en) (1H-azol-1-ylmethyl) subsitituted benzotriazole derivatives
GB8715925D0 (en) Thiapentanamide derivatives
GB2211840B (en) Indenofuran derivatives
IE871695L (en) Azabicycloalka(e)ne derivatives
GB8716085D0 (en) Amidino-&c derivatives
FI103571B1 (fi) Propoksibentseenijohdannaisia
LTIP1643A (en) 2-aniline-pyrimidine derivatives
IE871815L (en) Dihydroxycyclohexadiene derivatives
IE871782L (en) 18-phenyloestrane derivatives
IE871081L (en) Thiadiazinone - tricyclic derivatives